Idexx Laboratories (IDXX) Short term Debt (2016 - 2025)
Historic Short term Debt for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $455.0 million.
- Idexx Laboratories' Short term Debt rose 8200.0% to $455.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $455.0 million, marking a year-over-year increase of 8200.0%. This contributed to the annual value of $250.0 million for FY2024, which is 0.0% changed from last year.
- According to the latest figures from Q3 2025, Idexx Laboratories' Short term Debt is $455.0 million, which was up 8200.0% from $579.0 million recorded in Q2 2025.
- In the past 5 years, Idexx Laboratories' Short term Debt ranged from a high of $633.0 million in Q3 2022 and a low of $75.0 million during Q3 2021
- Over the past 5 years, Idexx Laboratories' median Short term Debt value was $250.0 million (recorded in 2022), while the average stood at $297.2 million.
- Per our database at Business Quant, Idexx Laboratories' Short term Debt crashed by 7432.93% in 2021 and then surged by 74411.25% in 2022.
- Idexx Laboratories' Short term Debt (Quarter) stood at $75.0 million in 2021, then surged by 233.35% to $250.0 million in 2022, then changed by 0.0% to $250.0 million in 2023, then changed by 0.0% to $250.0 million in 2024, then surged by 82.0% to $455.0 million in 2025.
- Its Short term Debt stands at $455.0 million for Q3 2025, versus $579.0 million for Q2 2025 and $319.5 million for Q1 2025.